Tag: common shares

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing  

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “Offering”) of common shares in the capital of the Company (the “Common Shares”).

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Kursat Kacira, the Chairman and President (the “Acquiror”) of Altai Resources Inc. (“Altai” or the “Company”), announced today that he has acquired a direct ownership of 373,843 common shares of the Company (the “Acquisition”), representing approximately 0.7% of the total issued and outstanding shares of the Company (the “Shares”). Prior to the Acquisition, the Acquiror directly owned 9,726,157 Shares, representing approximately 17.4% of the total issued and outstanding Shares, and indirectly owned 1,000,000 Shares, representing approximately 1.8% of the total issued and outstanding Shares. After giving effect to the Acquisition, the Acquiror has a combined direct and indirect ownership of 11,100,000 Shares, representing approximately 19.8% of the total issued and outstanding Shares. These shares are held for investment purposes.

CALGARY, Alberta, June 24, 2025 (GLOBE NEWSWIRE) -- FLINT Corp. (“FLINT”) (TSX: FLNT) is pleased to announce that all matters presented for approval at its annual meeting (the "Meeting") of holders of common shares ("Common Shares") held earlier today were approved. A total of 24,877,170 Common Shares, representing approximately 22.62% of the issued and outstanding Common Shares, were represented at the Meeting.